NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NASDAQ·Healthcare·Biotechnology
$27.92
-0.23%
Mkt Cap $3.78B
EPS — Estimate vs Actual
Mkt Cap
$3.78B
P/E
—
Fwd P/E
—
P/S
167.55
Rev TTM
—
EPS TTM
-$1.81
NASDAQ·Healthcare·Biotechnology
$27.92
-0.23%
Mkt Cap $3.78B
Mkt Cap
$3.78B
P/E
—
Fwd P/E
—
P/S
167.55
Rev TTM
—
EPS TTM
-$1.81